Loading company…
Riskpilot
← Back to search
Sign in
Get full access
IPharma Pro Sweden AB
AB
Active
Org 5594820374
Gullberg Sandåsen 1
Retail sale of pharmaceutical products · NACE 4773
Est. 2024
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 608K
EBITDA margin
63.6%
Equity ratio
50.2%
Financial strength
Net profit 2024
SEK 307K
0 employees
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Key figures
Annual report 2024
Revenue
SEK 608K
—
EBITDA
SEK 386K
—
Net profit
SEK 307K
—
Total assets
SEK 660K
—
Equity
SEK 332K
—
Employees
0
—
Company information
Legal name
IPharma Pro Sweden AB
Org number
5594820374
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
2 maj 2024
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultbolag för uppdrag inom läkemedelsbranschen.
Contact
Address
Gullberg Sandåsen 1
Email
mohammad.alabasse16@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Linköping
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
SEK thousands
Item
2024
Revenue
608
Staff expenses
−172
EBITDA
386
Depreciation & amort.
—
EBIT
386
Net financials
—
Profit before tax
386
Tax
−80
Net profit
307
Balance sheet
SEK thousands
Item
2024
Total assets
660
Equity
332
Long-term debt
—
Short-term debt
329
Total debt
329
Financial ratios
5-year trend
EBITDA margin
63.6%
This company
15.8%
Market median
+303% vs market
2024
2024
Equity ratio
50.2%
This company
38.2%
Market median
+31% vs market
2024
2024
Return on equity
92.5%
This company
18.4%
Market median
+403% vs market
2024
2024
Net profit margin
50.4%
This company
8.1%
Market median
+522% vs market
2024
2024
Asset turnover
0.92×
This company
1.12×
Market median
+18% vs market
2024
2024
Debt / equity
0.99×
This company
0.62×
Market median
+60% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-05-02 – 2024-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
MG
Mohammad Ghasan Al-Abasse
Board of Directors
2024
ZJ
Zahra Jabri
Deputy Board Member
2025
Former (1)
GM
Ghasan Mohammad Darweesh Al-Abasse
Deputy Board Member
2025 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of IPharma Pro Sweden AB also hold positions in
0
other companies.
Person
Role here
Other companies
Ghasan Mohammad Darweesh Al-Abasse
Deputy Board Member
0 companies
Mohammad Ghasan Al-Abasse
Board of Directors
0 companies
Zahra Jabri
Deputy Board Member
0 companies